Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Targeted Protein Degradation
83%
Degrader
50%
Confounding Factors
50%
Short-lived Protein
50%
Pan-KRAS
50%
Targeted Degradation
50%
Proteolysis Targeting chimera (PROTAC)
50%
GSPT1
33%
Protein Degradation
33%
Impactful Research
25%
Drug Discovery
16%
Stall
16%
Cytotoxic Agents
16%
Bona Fide
16%
Cytotoxic Compounds
16%
Mathematical Modeling
16%
Target Selection
16%
Screening Effort
16%
Doxorubicin
16%
Controlled Experiment
16%
Myeloid Cell leukemia-1 (Mcl-1)
16%
Protein Half-life
16%
Novel Agents
16%
Protein Synthesis
16%
Dramatic Effect
16%
Control Types
16%
Murine Double Minute 2 (MDM2)
16%
Targeted Protein Degraders
16%
KRAS-driven Cancer
16%
Natural Protein
16%
Allosteric Inhibitor
12%
Improved Outcomes
12%
Selective Targeting
12%
Target Resistance
12%
Physicochemical Properties
12%
Biological Systems
12%
Targeting Efficacy
12%
In Vivo Performance
12%
Chemical Intervention
12%
Resistance Management
12%
Ubiquitin-proteasome System
12%
Protein Surface
12%
Allosteric Targeting
12%
Protein Degrader
12%
Conceptual Challenges
12%
Pharmacology, Toxicology and Pharmaceutical Science
Doxorubicin
50%
Cytotoxic Agent
50%
Malignant Neoplasm
50%
Carcinogenesis
50%
Drug Discovery
50%
Cysteine
16%
Tumor Regression
16%
Connective Tissue Cancer
16%
Rat
16%
Amino Acid
16%
Biochemistry, Genetics and Molecular Biology
Protein Catabolism
100%
Proteolysis
50%
Half-Life
25%
Protein Biosynthesis
12%
MCL1
12%
Doxorubicin
12%
Drug Development
12%
